BitFrontier Capital Holdings Appoints John P. Gorst as CEO Ahead of Ancient Extracts USA Acquisition
BitFrontier Capital Holdings (BFCH) names veteran operator John P. Gorst as CEO as it nears closing the acquisition of Ancient Extracts USA, signaling a strategic shift toward operational scaling and platform expansion in the wellness sector.
BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., has appointed John P. Gorst as Chief Executive Officer as the company advances toward closing its acquisition of Ancient Extracts USA and expands its wellness platform. The announcement, made on May 14, 2026, highlights a strategic leadership transition aimed at operational execution and growth.
Jordan P. Balencic, who previously served as CEO, will remain Chairman and transition to Chief Science Officer, focusing on strategic growth initiatives, product development, and commercialization. Dr. Balencic emphasized the complementary nature of the new leadership structure, stating, "Ancient Extracts USA already has a commercial foundation in place, and Mr. Gorst brings decades of operational, manufacturing, consumer products, and capital markets experience."
Gorst brings over 30 years of experience in public company leadership, consumer products, manufacturing, and capital markets. He has participated in raising more than $100 million through equity financings, PIPE transactions, and debt offerings, and has been involved in two eight-figure business exits. His appointment is expected to strengthen operational execution, acquisition integration, and fundraising efforts as BFCH builds a scalable wellness platform.
The leadership change comes as BFCH works to finalize definitive agreements for the acquisition of Ancient Extracts USA, a post-revenue wellness platform with direct-to-consumer infrastructure, a growing customer base, and active commercialization initiatives. Management expects to announce initial purchase orders and commercial developments following the closing.
Gorst will also immediately begin forming audit and compensation committees to enhance corporate governance, support future audits, expand the Board of Directors, and recruit additional C-level executives. The company intends to align executive compensation with long-term operational execution and shareholder value creation.
Dr. Balencic noted that the acquisition is part of a broader strategy: "This is not about a single acquisition. We are building a scalable operating platform focused on consumer wellness, commercialization, and strategic growth opportunities." Gorst added, "I believe there is a significant opportunity to scale the platform through disciplined execution, expanded distribution, strategic partnerships, and additional operating assets."
The company continues to evaluate additional acquisition opportunities and strategic partnerships aligned with its focus on consumer wellness, functional products, and human optimization. For more information, visit UNLOCKDinc.com and view filings on OTC Markets.
The appointment underscores BFCH's commitment to building a compliant, transparent operating platform at the intersection of human optimization and brand development, following the elimination of legacy debt and implementation of modern capital frameworks.